Vagotomy attenuates brain cytokines and sleep induced by peripherally administered tumor necrosis factor-α and lipopolysaccharide in mice

Sleep

Volumn 36, Issue 8, 2013, Pages 1227-1238

  Zielinski, Mark R ^a   Dunbrasky, Danielle L ^a   Taishi, Ping ^a   Souza, Gianne ^a   Krueger, James M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

EEG; Interleukin 1 ; Lipopolysaccharide; Mouse; Sleep; Tumor necrosis factor ; Vagal afferents; Vagotomy

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; GENE EXPRESSION; INFLAMMATION; MALE; MOUSE; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SENSORY NERVE; SLEEP; VAGOTOMY; VAGUS NERVE;

EEG; INTERLEUKIN-1Β; LIPOPOLYSACCHARIDE; MOUSE; SLEEP; TUMOR NECROSIS FACTOR-Α; VAGAL AFFERENTS; VAGOTOMY;

ANIMALS; BRAIN CHEMISTRY; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; POLYSOMNOGRAPHY; SLEEP; SLEEP STAGES; TUMOR NECROSIS FACTOR-ALPHA; VAGOTOMY; VAGUS NERVE;

EID: 84881186708     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2892     Document Type: Article

References (72)

1. Khalyfa A, Serpero LD, Kheirandish-Gozal L, Capdevila OS, Gozal D. TNF-α gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr 2011;158: 77-82.
2. Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK. TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med 2009;103: 386-92.
3. Chennaoui M, Sauvet F, Drogou C, et al. Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-α) levels in healthy men. Cytokine 2011;56: 318-24.
4. Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immun 2010;24: 54-7.
5. Haack M, Pollmächer T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun 2004;18: 361-7.
6. Shearer WT, Reuben JM, Mullington JM, et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001;107: 165-70.
7. Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004;126: 1473-9.
8. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82: 1313-6.
9. Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008;68: 323-8.
10. Swaroop JJ, Rajarajeswari D, Naidu JN. Association of TNF-α with insulin resistance in type 2 diabetes mellitus. Indian J Med Res 2012;135: 127-30.
11. Kozachik SL, Bandeen-Roche K. Predictors of patterns of pain, fatigue, and insomnia during the first year after a cancer diagnosis in the elderly. Cancer Nurs 2008;31: 334-44.
12. Nakanishi-Minami T, Kishida K, Funahashi T, Shimomura I. Sleepwake cycle irregularities in type 2 diabetics. Diabetol Metab Syndr 2012;4: 18-24.
13. Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des 2008;14: 3408-16.
14. Yehuda S, Sredni B, Carasso RL, Kenigsbuch-Sredni D. REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J Interferon Cytokine Res 2009;29: 393-8.
15. Zielinski MR, Taishi P, Clinton JM, Krueger JM. 5'- Ectonucleotidaseknockout mice lack non-REM sleep responses to sleep deprivation. Eur J Neurosci 2012;35: 1789-98.
16. Ramesh V, Nair D, Zhang SX, et al. Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-alpha pathway. J Neuroinflammation 2012;11:91.
17. Zielinski MR, Krueger JM. Sleep and innate immunity. Front Biosci (Schol Ed) 2011;3: 632-42.
18. Floyd RA, Krueger JM. Diurnal variation of TNF alpha in the rat brain. Neuroreport 19973;8: 915-8.
19. Bredow S, Guha-Thakurta N, Taishi P, Obál F Jr, Krueger JM. Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroimmunomodulation 1997;4: 84-90.
20. Fang J, Wang Y, Krueger JM. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFalpha treatment. J Neurosci 1997;17: 5949-55.
21. Kapás L, Bohnet SG, Traynor TR, et al. Spontaneous and influenza virusinduced sleep are altered in TNF-alpha double-receptor deficient mice. J Appl Physiol 2008;105: 1187-98.
22. Davis CJ, Clinton JM, Jewett KA, Zielinski MR, Krueger JM. Delta wave power: an independent sleep phenotype or epiphenomenon? J Clin Sleep Med 2011;7:S16-8.
23. Shoham S, Davenne D, Cady AB, Dinarello CA, Krueger JM. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 1987;253:R142-9.
24. Kubota T, Li N, Guan Z, Brown RA, Krueger JM. Intrapreoptic microinjection of TNF-alpha enhances non-REM sleep in rats. Brain Res 2002;932: 37-44.
25. Kubota T, Fang J, Guan Z, Brown RA, Krueger JM. Vagotomy attenuates tumor necrosis factor-alpha-induced sleep and EEG delta-activity in rats. Am J Physiol Regul Integr Comp Physiol 2001;280:R1213-20.
26. Lancel M, Mathias S, Schiffelholz T, Behl C, Holsboer F. Soluble tumor necrosis factor receptor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period. Brain Res 1997;770: 184-91.
27. Opp MR, Toth LA. Somnogenic and pyrogenic effects of interleukin- 1beta and lipopolysaccharide in intact and vagotomized rats. Life Sci 1998;62: 923-36.
28. Kapás L, Hansen MK, Chang HY, Krueger JM. Vagotomy attenuates but does not prevent the somnogenic and febrile effects of lipopolysaccharide in rats. Am J Physiol 1998;274:R406-11.
29. Krueger JM, Kubillus S, Shoham S, Davenne D. Enhancement of slowwave sleep by endotoxin and lipid A. Am J Physiol 1986;251:R591-7.
30. Imeri L, Bianchi S, Opp MR. Inhibition of caspase-1 in rat brain reduces spontaneous nonrapid eye movement sleep and nonrapid eye movement sleep enhancement induced by lipopolysaccharide. Am J Physiol Regul Integr Comp Physiol 2006;291:R197-204.
31. Schiffelholz T, Lancel M. Sleep changes induced by lipopolysaccharide in the rat are influenced by age. Am J Physiol Regul Integr Comp Physiol 2001;280:R398-403.
32. Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 2004;201: 197-207.
33. Sah SP, Tirkey N, Kuhad A, Chopra K. Effect of quercetin on lipopolysaccharide induced-sickness behavior and oxidative stress in rats. Indian J Pharmacol 2011;43: 192-6.
34. Taishi P, Davis CJ, Bayomy O, et al. Brain-specific interleukin-1 receptor accessory protein in sleep regulation. J Appl Physiol 2012;112: 1015-22.
35. Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun 2010;24: 102-9.
36. Hansen MK, Krueger JM. Subdiaphragmatic vagotomy blocks the sleep- and fever-promoting effects of interleukin-1beta. Am J Physiol 1997;273:R1246-53.
37. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 1995;692: 244-50.
38. Hansen MK, Taishi P, Chen Z, Krueger JM. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J Neurosci 1998;18: 2247-53.
39. Layé S, Bluthé RM, Kent S, et al. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol 1995;268:R1327-31.
40. Ono A, Okuma Y, Hosoi T, Nomura Y. Effect of subdiaphragmatic vagotomy on bacterial DNA-induced IL-1beta expression in the mouse hypothalamus. Brain Res 2004;1028: 233-7.
41. Marquette C, Linard C, Galonnier M, et al. IL-1beta, TNF-alpha and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. Int J Radiat Biol 2003;79: 777-85.
42. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981;213: 1036-7.
43. West MA, Clair L, Kraatz J, Rodriguez JL. Endotoxin tolerance from lipopolysaccharide pretreatment induces nuclear factor-kappa B alterations not present in C3H/HeJ mice. J Trauma 2000;49: 298-305.
44. Greisman SE, Hornick RB. The nature of endotoxin tolerance. Trans Am Clin Climatol Assoc 1975;86: 43-50.
45. Jakubcakova V, Flachskamm C, Deussing JM, Kimura M. Deficiency of corticotropin-releasing hormone type-2 receptor alters sleep responses to bacterial lipopolysaccharide in mice. Brain Behav Immun 2011;25: 1626-36.
46. Taishi P, De A, Alt J, Gardi J, Obal F Jr, Krueger JM. Interleukin-1beta stimulates growth hormone-releasing hormone receptor mRNA expression in the rat hypothalamus in vitro and in vivo. J Neuroendocrinol 2004;16: 113-8.
47. Hansen MK, Kapas L, Fang J, Krueger JM. Cafeteria diet-induced sleep is blocked by subdiaphragmatic vagotomy in rats. Am J Physiol 1998;274;R168-R174.
48. Churchill L, Taishi P, Wang M, et al. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha. Brain Res 2006;1120: 64-73.
49. Zanchetti A, Wang SC, Moruzzi G. The effect of vagal afferent stimulation on the EEG pattern of the cat. Electroencephalogr Clin Neurophysiol 1952;4:357.
50. Chase MH, Nakamura Y, Clements CD. Afferent vagal stimulation: neurographic correlates of induced EEG synchronization and desynchronization. Brain Res 1967;5: 236-49.
51. Chase MH, Nakamura Y. Cortical and subcortical EEG patterns of response to afferent abdominal vagal stimulation: Neurographic correlates. Physiol Behav 1968;3: 605-10.
52. Rizzo P, Beelke M, De Carli F, et al. Modifications of sleep EEG induced by chronic vagus nerve stimulation in patients affected by refractory epilepsy. Clin Neurophysiol 2004;115: 658-64.
53. Hofle N, Paus T, Reutens D, et al. Regional cerebral blood flow changes as a function of delta and spindle activity during slow wave sleep in humans. J Neurosci 1997;4800-8.
54. Gerashchenko D, Matsumura H. Continuous recordings of brain regional circulation during sleep/wake state transitions in rats. Am J Physiol 1996;270:R855-63.
55. Henny P, Jones BE. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci 2008;27: 654-70.
56. Breder CD, Hazuka C, Ghayur T, et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci U S A 1994;91: 11393-7.
57. Park SE, Dantzer R, Kelley KW, McCusker RH. Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J Neuroinflammation 2011;8:12.
58. Johnston GR, Webster NR. Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth 2009;102: 453-62.
59. Yang I, Han SJ, Kaur G, Crane C, Parsa AT. The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci 2010;17: 6-10.
60. Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol 2012;33: 116-25.
61. Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991;87: 1360-6.
62. Nishioku T, Matsumoto J, Dohgu S, et al. Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J Pharmacol Sci 2010;112: 251-4.
63. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010;37: 26-32.
64. Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol 2009;9:S3.
65. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000;27: 422-7.
66. Croft M, Duan W, Choi H, Eun SY, Madireddi S, Mehta A. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 2012;33: 144-52.
67. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999;19: 314-6.
68. Riha RL, Brander P, Vennelle M, et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005;26: 673-8.
69. Zielinski MR, Krueger JM. Inflammation and Sleep. In: Barkoukis TJ, Matheson JK, Ferber R, Doghramji K, eds. Therapy in sleep medicine. Philadelphia, PA: Saunders, 2012;607-16.
70. Krueger JM, Rector DM, Churchill L. Sleep and cytokines. Sleep Med Clin 2007;2: 161-9.
71. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009;265: 663-79.
72. Vgontzas AN, Chrousos GP. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin North Am 2002;31:15-36.